Physician digital marketing & sales trends webcast

Taking the Pulse® U.S. — Physicians and Emerging Information Technologies, is a syndicated multi-client physician research study and advisory service focused on understanding technology adoption and integration trends among U.S. practicing physicians. Now in its seventh year, the primary objective of the research study is to track which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future.

Taking the Pulse® v8.0 was fielded in Q1 2008 among 1,832 practicing U.S. physicians. Covering subjects that ranges from

  • General Access and Technology Profile: Practice technology profile, frequency of Internet use, frequency of professional activities online
  • Online and Offline Professional Information Sources: Online and offline information sources used, including textbooks, journals, CME, reps, search engines, sites visited, conditions researched
  • Detailing and Pharma Services: eDetailing participation and future interest, use and interest in full-service portals, product and corporate site visitation, rep technology usage
  • Web 2.0 Technologies: Awareness and use of streaming video, blogs, podcasting and social networking, including use of sites such as Sermo
  • Email Use and Opportunity: Email newsletters, email with patients, colleagues, and pharmaceutical, biotech or device companies
  • Patient Interaction and Education: Patients bringing information into office, sites recommended to patients, types of patient education sources of interest
  • Digital Health Infrastructure: ePrescribing, EMR, Practice Management, Speed of Access
  • Mobile Technology Profile: PDA, Mobile Phone, Internet, Mobile Integration, iPods, MP3 players and tablet PCs

The Webinar is on June 5 2008, by Manhattan Research about physician digital marketing & sales trends webcast –register at manhattanresearch.webex.com

Note: as is from manhattanresearch website

Pepsi selling Food containing Genetically Modified Products

Tests commissioned by Greenpeace, shown that Pepsico’s Doritos Corn Chips contains Genetically Modified Mon 863 and NK 603 variety corn ingredients.

Both Mon 863 and NK 603 are Monsanto’s genetically modified corn varieties. Mon 863 has a bacterial gene to give pest tolerance, while NK 603 has a bacterial gene for herbicide tolerance. An Independent analysis last year, done by the Committee for Independent Research and Information On Genetic Engineering and French National Committee For Risk Assessment of GMOs had concluded that both Mon 863 and NK 603 pose serious health impacts.

The find comes from India by Greenpeas after  an independent laboratory in germany conducted Tests on products picked up randomly from a supermarket in New Delhi.

Under existing Indian laws this is illegal practice. Every importer is required to label the products containing any GM content as well as get prior approval from the Genetic Engineering Approval Committee which falls under the environment ministry.

Surprisingly in 2007 United Arba Emirates have confirmed that 40% of the food in the UAE is genetically modified yet is sold to the end users without proper labelling.

While in Europe if an item contains more than 0.9 per cent of GMOs it is required to carry a label.

Its growing concern among many developing countries that import products from US where Monsanto dominates the food chain with its GM seeds. And it is going to create more controversy as Monsanto has aggressive plans in milk production. It already has a product on Bovine somatotropin a natural protein produced in the pituitary glands of all cattle which helps adult cows to produce milk. Monsanto’s version of Bovine somatotropin is a leading dairy animal health product in the United States and many other countries.

%d bloggers like this: